High LDL causes: Difference between revisions
Rim Halaby (talk | contribs) No edit summary |
|||
(31 intermediate revisions by 3 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{LDL}} | {{LDL}} | ||
{{CMG}}; {{AE}} {{CZ}}; {{Rim}} | {{CMG}}; {{AE}} {{CZ}}; {{Rim}}; {{VR}} | ||
==Overview== | ==Overview== | ||
High LDL can be primary or secondary to [[Saturated fat|diet high in saturated fat]], [[hypothyroidism]], [[nephrotic syndrome]], [[pregnancy]], [[obesity]], or medications such as [[amiodarone]], [[cyclosporine]], [[diuretics]], and [[glucocorticoids]].<ref name="pmid24239923">{{cite journal| author=Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH et al.| title=2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. | journal=J Am Coll Cardiol | year= 2014 | volume= 63 | issue= 25 Pt B | pages= 2889-934 | pmid=24239923 | doi=10.1016/j.jacc.2013.11.002 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24239923 }} </ref> High LDL can also be caused by [[inherited]] diseases that affect the [[lipid metabolism]]. | |||
==Causes | ==Causes== | ||
* | ===Life Threatening Causes=== | ||
* [[ | Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated. | ||
* | |||
* High fat diet | High LDL does not have any life-threatening cause. | ||
* [[ | |||
* [[Nephrotic | ===Common Causes=== | ||
* Obstructive liver disease | * [[Amiodarone]] | ||
* Primary hyperlipoproteinemia | * [[Anorexia]] | ||
* [[Biliary obstruction]] | |||
* [[Cyclosporine]] | |||
* [[Diuretics]] | |||
*[[Familial hypercholesterolemia]]<ref name="Durrington-2003">{{Cite journal | last1 = Durrington | first1 = P. | title = Dyslipidaemia. | journal = Lancet | volume = 362 | issue = 9385 | pages = 717-31 | month = Aug | year = 2003 | doi = 10.1016/S0140-6736(03)14234-1 | PMID = 12957096 }}</ref> | |||
* [[Glucocorticoids]] | |||
*[[Saturated fat|High saturated fat diet]]<ref name="Covington-2004">{{Cite journal | last1 = Covington | first1 = MB. | title = Omega-3 fatty acids. | journal = Am Fam Physician | volume = 70 | issue = 1 | pages = 133-40 | month = Jul | year = 2004 | doi = | PMID = 15259529 }}</ref> | |||
* [[Hypothyroidism]] | |||
* [[Nephrotic syndrome]] | |||
* [[Obesity]] | |||
* [[Pregnancy]] | |||
* [[Weight gain]]<ref name="pmid24239923">{{cite journal| author=Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH et al.| title=2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. | journal=J Am Coll Cardiol | year= 2014 | volume= 63 | issue= 25 Pt B | pages= 2889-934 | pmid=24239923 | doi=10.1016/j.jacc.2013.11.002 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24239923 }} </ref> | |||
===Causes by Organ System=== | |||
{|style="width:80%; height:100px" border="1" | |||
|style="height:100px"; style="width:25%" border="1" bgcolor="LightSteelBlue" | '''Cardiovascular''' | |||
|style="height:100px"; style="width:75%" border="1" bgcolor="Beige" | No underlying causes | |||
|- | |||
|-bgcolor="LightSteelBlue" | |||
| '''Chemical/Poisoning''' | |||
|bgcolor="Beige"| [[Terpenoid|Diterpenoids]] | |||
|- | |||
|-bgcolor="LightSteelBlue" | |||
| '''Dental''' | |||
|bgcolor="Beige"| No underlying causes | |||
|- | |||
|-bgcolor="LightSteelBlue" | |||
| '''Dermatologic''' | |||
|bgcolor="Beige"| No underlying causes | |||
|- | |||
|-bgcolor="LightSteelBlue" | |||
| '''Drug Side Effect''' | |||
|bgcolor="Beige"| [[Amiodarone]], [[atazanavir]], [[azathioprine]], [[bexarotene]], [[Immunosuppressive drug#Drugs acting on immunophilins|calcineurin inhibitors]], [[chlortalidone]], [[corticosteroids]], [[cyclosporine]], [[Dapagliflozin]], [[Danazol]], [[desvenlafaxine]], [[diuretics]], [[Fish oil|fish oil supplements]], [[glucocorticoid]], [[immunosuppressive agents]], [[levonorgestrel]], [[lopinavir]], [[Medroxyprogesterone acetate]], [[mycophenolate]], [[nicotine]], [[norgestrel]], [[Norgestrel and Ethinyl estradiol]], [[prednisone]], [[progestin]], [[rapamycin]], [[rosiglitazone]], [[sirolimus]], [[thiazide]], [[tocilizumab]] | |||
|- | |||
|-bgcolor="LightSteelBlue" | |||
| '''Ear Nose Throat''' | |||
|bgcolor="Beige"| No underlying causes | |||
|- | |||
|-bgcolor="LightSteelBlue" | |||
| '''Endocrine''' | |||
|bgcolor="Beige"| [[Androgens]], [[dehydroepiandrosterone]], [[growth hormone deficiency]], [[hypercortisolism]], [[hypothyroidism]], [[polycystic ovarian syndrome]], [[progestagens]], [[Hypothyroidism|subclinical hypothyroidism]], [[testosterone]] | |||
|- | |||
|-bgcolor="LightSteelBlue" | |||
| '''Environmental''' | |||
|bgcolor="Beige"| No underlying causes | |||
|- | |||
|-bgcolor="LightSteelBlue" | |||
| '''Gastroenterologic''' | |||
|bgcolor="Beige"| [[Biliary obstruction]] | |||
|- | |||
|-bgcolor="LightSteelBlue" | |||
| '''Genetic''' | |||
|bgcolor="Beige"| [[Niemann-Pick disease|Acid sphingomyelinase deficiency]], [[Familial hypercholesterolemia|autosomal recessive hypercholesterolemia]], [[familial combined hyperlipidemia]], [[Apolipoprotein B deficiency|familial defective apolipoprotein B-100]], [[familial hypercholesterolemia]], [[Interleukin 28#Clinical Significance|IL 28B polymorphisms]], [[Niemann-Pick disease]], [[hypercholesterolemia|polygenic hypercholesterolemia]] | |||
|- | |||
|-bgcolor="LightSteelBlue" | |||
| '''Hematologic''' | |||
|bgcolor="Beige"| No underlying causes | |||
|- | |||
|-bgcolor="LightSteelBlue" | |||
| '''Iatrogenic''' | |||
|bgcolor="Beige"| No underlying causes | |||
|- | |||
|-bgcolor="LightSteelBlue" | |||
| '''Infectious Disease''' | |||
|bgcolor="Beige"| [[Gram negative bacteremia]], [[H. pylori]], [[small bowel bacterial overgrowth syndrome]] | |||
|- | |||
|-bgcolor="LightSteelBlue" | |||
| '''Musculoskeletal/Orthopedic''' | |||
|bgcolor="Beige"| No underlying causes | |||
|- | |||
|-bgcolor="LightSteelBlue" | |||
| '''Neurologic''' | |||
|bgcolor="Beige"| No underlying causes | |||
|- | |||
|-bgcolor="LightSteelBlue" | |||
| '''Nutritional/Metabolic''' | |||
|bgcolor="Beige"| [[Chenodeoxycholic acid]], [[Carbohydrate#Nutrition|high carbohydrate diet]], [[Saturated fat|high saturated fat diet]], [[Omega-3 fatty acid|omega-3 polyunsaturated fatty acids]], [[Hypercholesterolemia|polygenic hypercholesterolemia]], [[primary hyperlipoproteinemia]], [[Hypolipoproteinemia pathophysiology#Primary Lipoprotein Disorders|primary hypolipoproteinemia]], [[selenium deficiency]] | |||
|- | |||
|-bgcolor="LightSteelBlue" | |||
| '''Obstetric/Gynecologic''' | |||
|bgcolor="Beige"| [[Polycystic ovarian syndrome]], [[pregnancy]] | |||
|- | |||
|-bgcolor="LightSteelBlue" | |||
| '''Oncologic''' | |||
|bgcolor="Beige"| No underlying causes | |||
|- | |||
|-bgcolor="LightSteelBlue" | |||
| '''Ophthalmologic''' | |||
|bgcolor="Beige"| No underlying causes | |||
|- | |||
|-bgcolor="LightSteelBlue" | |||
| '''Overdose/Toxicity''' | |||
|bgcolor="Beige"| No underlying causes | |||
|- | |||
|-bgcolor="LightSteelBlue" | |||
| '''Psychiatric''' | |||
|bgcolor="Beige"| No underlying causes | |||
|- | |||
|-bgcolor="LightSteelBlue" | |||
| '''Pulmonary''' | |||
|bgcolor="Beige"| No underlying causes | |||
|- | |||
|-bgcolor="LightSteelBlue" | |||
| '''Renal/Electrolyte''' | |||
|bgcolor="Beige"| [[Chronic kidney disease]], [[nephrotic syndrome]] | |||
|- | |||
|-bgcolor="LightSteelBlue" | |||
| '''Rheumatology/Immunology/Allergy''' | |||
|bgcolor="Beige"| [[Dysproteinemia]], [[lipopolysaccharides]], [[monoclonal gammopathy]], [[paraproteinemia]] | |||
|- | |||
|-bgcolor="LightSteelBlue" | |||
| '''Sexual''' | |||
|bgcolor="Beige"| No underlying causes | |||
|- | |||
|-bgcolor="LightSteelBlue" | |||
| '''Trauma''' | |||
|bgcolor="Beige"| No underlying causes | |||
|- | |||
|-bgcolor="LightSteelBlue" | |||
| '''Urologic''' | |||
|bgcolor="Beige"| No underlying causes | |||
|- | |||
|-bgcolor="LightSteelBlue" | |||
| '''Miscellaneous''' | |||
|bgcolor="Beige"| [[Anorexia]], [[obesity]], [[weight gain]] | |||
|- | |||
|} | |||
===Causes in Alphabetical Order=== | |||
{{col-begin|width=80%}} | |||
{{col-break|width=33%}} | |||
*[[Niemann-Pick disease|Acid sphingomyelinase deficiency]] | |||
* [[Amiodarone]] | |||
*[[Androgens]] | |||
* [[Anorexia]] | |||
*[[Atazanavir]] | |||
*[[Familial hypercholesterolemia|Autosomal recessive hypercholesterolemia]] | |||
*[[Azathioprine]] | |||
*[[Bexarotene]] | |||
* [[Biliary obstruction]] | |||
*[[Immunosuppressive drug#Drugs acting on immunophilins|Calcineurin inhibitors]] | |||
*[[Chenodeoxycholic acid]] | |||
*[[Chlortalidone]] | |||
*[[Cholestatic jaundice]] | |||
*[[Chronic kidney disease]] | |||
*[[Chronic liver disease]] | |||
*[[Corticosteroids]] | |||
*[[Cyclosporine]] | |||
*[[Dehydroepiandrosterone]] | |||
*[[Desvenlafaxine]] | |||
*[[Terpenoid|Diterpenoids]] | |||
* [[Diuretics]] | |||
*[[Dysproteinemia]] | |||
*[[Familial combined hyperlipidemia]] | |||
*[[Apolipoprotein B deficiency|Familial defective apolipoprotein B-100]] | |||
{{col-break|width=33%}} | |||
*[[Familial hypercholesterolemia]]<ref name="Durrington-2003">{{Cite journal | last1 = Durrington | first1 = P. | title = Dyslipidaemia. | journal = Lancet | volume = 362 | issue = 9385 | pages = 717-31 | month = Aug | year = 2003 | doi = 10.1016/S0140-6736(03)14234-1 | PMID = 12957096 }}</ref> | |||
*[[Fish oil|Fish oil supplements]]<ref name="Pejic-">{{Cite journal | last1 = Pejic | first1 = RN. | last2 = Lee | first2 = DT. | title = Hypertriglyceridemia. | journal = J Am Board Fam Med | volume = 19 | issue = 3 | pages = 310-6 | month = | year = | doi = | PMID = 16672684 }}</ref> | |||
* [[Glucocorticoid]] | |||
*[[Gram negative bacteremia]] | |||
*[[Growth hormone deficiency]] | |||
*[[H. pylori]] | |||
*[[Carbohydrate#Nutrition|High carbohydrate diet]] | |||
*[[Saturated fat|High saturated fat diet]]<ref name="Covington-2004">{{Cite journal | last1 = Covington | first1 = MB. | title = Omega-3 fatty acids. | journal = Am Fam Physician | volume = 70 | issue = 1 | pages = 133-40 | month = Jul | year = 2004 | doi = | PMID = 15259529 }}</ref> | |||
*[[Hypercortisolism]] | |||
*[[Hypothyroidism]] | |||
*[[Interleukin 28#Clinical Significance|IL 28B polymorphisms]] | |||
*[[Immunosuppressive agents]] | |||
*[[LDL receptor deficiency]] | |||
*[[Levonorgestrel]] | |||
*[[Lipopolysaccharides]] | |||
*[[Lopinavir]] | |||
*[[Monoclonal gammopathy]] | |||
*[[Mycophenolate]] | |||
*[[Nephrotic syndrome]]<ref name="Kronenberg-2005">{{Cite journal | last1 = Kronenberg | first1 = F. | title = Dyslipidemia and nephrotic syndrome: recent advances. | journal = J Ren Nutr | volume = 15 | issue = 2 | pages = 195-203 | month = Apr | year = 2005 | doi = | PMID = 15827892 }}</ref> | |||
*[[Nicotine]] | |||
*[[Niemann-Pick disease]] | |||
*[[Norgestrel]] | |||
*[[Norgestrel and Ethinyl estradiol]] | |||
* [[Obesity]] | |||
*[[Xanthomatous biliary cirrhosis|Obstructive liver disease]] | |||
{{col-break|width=33%}} | |||
*[[Omega-3 fatty acid|Omega-3 polyunsaturated fatty acids]] | |||
*[[Pancreatitis]] | |||
*[[Paraproteinemia]] | |||
*[[Polycystic ovarian syndrome]] | |||
* [[Pregnancy]] | |||
*[[Hypercholesterolemia|Polygenic hypercholesterolemia]] | |||
*[[Prednisone]] | |||
*[[Primary biliary cirrhosis]] | |||
*[[Primary hyperlipoproteinemia]] | |||
*[[Hypolipoproteinemia pathophysiology#Primary Lipoprotein Disorders|Primary hypolipoproteinemia]] | |||
*[[Progestagens]] | |||
*[[Progestin]] | |||
*[[Rapamycin]] | |||
*[[Rosiglitazone]] | |||
*[[Selenium deficiency]] | |||
*[[Sirolimus]] | |||
*[[Small bowel bacterial overgrowth syndrome]] | |||
*[[Hypothyroidism|Subclinical hypothyroidism]] | |||
*[[Testosterone]] | |||
*[[Thiazide]] | |||
*[[Tocilizumab]] | |||
* [[Weight gain]] | |||
{{col-end}} | |||
==References== | ==References== |
Latest revision as of 21:44, 16 January 2015
Low Density Lipoprotein Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
High LDL causes On the Web |
American Roentgen Ray Society Images of High LDL causes |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Cafer Zorkun, M.D., Ph.D. [2]; Rim Halaby, M.D. [3]; Vendhan Ramanujam M.B.B.S [4]
Overview
High LDL can be primary or secondary to diet high in saturated fat, hypothyroidism, nephrotic syndrome, pregnancy, obesity, or medications such as amiodarone, cyclosporine, diuretics, and glucocorticoids.[1] High LDL can also be caused by inherited diseases that affect the lipid metabolism.
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.
High LDL does not have any life-threatening cause.
Common Causes
- Amiodarone
- Anorexia
- Biliary obstruction
- Cyclosporine
- Diuretics
- Familial hypercholesterolemia[2]
- Glucocorticoids
- High saturated fat diet[3]
- Hypothyroidism
- Nephrotic syndrome
- Obesity
- Pregnancy
- Weight gain[1]
Causes by Organ System
Causes in Alphabetical Order
References
- ↑ 1.0 1.1 Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH; et al. (2014). "2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines". J Am Coll Cardiol. 63 (25 Pt B): 2889–934. doi:10.1016/j.jacc.2013.11.002. PMID 24239923.
- ↑ 2.0 2.1 Durrington, P. (2003). "Dyslipidaemia". Lancet. 362 (9385): 717–31. doi:10.1016/S0140-6736(03)14234-1. PMID 12957096. Unknown parameter
|month=
ignored (help) - ↑ 3.0 3.1 Covington, MB. (2004). "Omega-3 fatty acids". Am Fam Physician. 70 (1): 133–40. PMID 15259529. Unknown parameter
|month=
ignored (help) - ↑ Pejic, RN.; Lee, DT. "Hypertriglyceridemia". J Am Board Fam Med. 19 (3): 310–6. PMID 16672684.
- ↑ Kronenberg, F. (2005). "Dyslipidemia and nephrotic syndrome: recent advances". J Ren Nutr. 15 (2): 195–203. PMID 15827892. Unknown parameter
|month=
ignored (help)